High incidence of skin rash in patients with hairy cell leukemia treated with cladribine

References

• Grever MR. How I treat hairy cell leukemia. Blood 2010;115:21–28.
   PubMed Web of Science ®Google Scholar
• Quesada JR, Reuben J, Manning JT, . Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984;310:15–18.
   PubMed Web of Science ®Google Scholar
• Spiers AS, Parekh SJ, Bishop MB. Hairy-cell leukemia: induction of complete remission with pentostatin (2’-deoxycoformycin). J Clin Oncol 1984;2:1336–1342.
   PubMed Web of Science ®Google Scholar
• Piro LD, Carrera CJ, Carson DA, . Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117–1121.
   PubMed Web of Science ®Google Scholar
• Goodman GR, Burian C, Koziol JA, . Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891–896.
   PubMed Web of Science ®Google Scholar
• Saven A, Burian C, Koziol JA, . Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918–1926.
   PubMed Web of Science ®Google Scholar
• Urba WJ, Baseler MW, Kopp WC, . Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood 1989;73:38–46.
   PubMed Web of Science ®Google Scholar
• Seymour JF, Kurzrock R, Freireich EJ, . 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4 + lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906–2911.
   PubMed Web of Science ®Google Scholar
• Juliusson G, Lenkei R, Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994;83:3672–3681.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Hakimian D, Variakojis D, . A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992;80:2203–2209.
   PubMed Web of Science ®Google Scholar
• Meunier P, Castaigne S, Bastie JN, . Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol 1996;76:385–386.
   PubMed Web of Science ®Google Scholar
• Grey MR, Flanagan NG, Kelsey PR. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Clin Lab Haematol 2000;22: 111–113.
   PubMedGoogle Scholar
• Hendrick A. Purpuric rash following treatment with 2-chlorodeoxyadenosine. Clin Lab Haematol 2001;23:67–68.
   PubMedGoogle Scholar
• Chubar Y, Bennett M. Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. Br J Haematol 2003;122:768–770.
   PubMed Web of Science ®Google Scholar
• Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683–693.
   PubMed Web of Science ®Google Scholar
• Emmerson BT, Hazelton RA, Frazer IH. Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum 1988;31:436–440.
   PubMed Web of Science ®Google Scholar
• Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 2003;24:201–220.
   PubMed Web of Science ®Google Scholar
• McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis 1981;40:245–249.
   PubMed Web of Science ®Google Scholar
• Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982;4:426–428.
   PubMedGoogle Scholar
• Seymour JF, Talpaz M, Kurzrock R. Response duration and recovery of CD4 + lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up. Leukemia 1997;11:42–47.
   PubMed Web of Science ®Google Scholar
• Kraut EH, Neff JC, Bouroncle BA, . Immunosuppressive effects of pentostatin. J Clin Oncol 1990;8:848–855.
   PubMed Web of Science ®Google Scholar
• Rafel M, Cervantes F, Beltran JM, . Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients. Cancer 2000;88:352–357.
   PubMed Web of Science ®Google Scholar
• Johnston JB, Glazer RI, Pugh L, . The treatment of hairy-cell leukaemia with 2’-deoxycoformycin. Br J Haematol 1986;63:525–534.
   PubMed Web of Science ®Google Scholar
• Cook S, Vermersch P, Comi G, . Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Mult Scler 2011;17: 578–593.
   PubMed Web of Science ®Google Scholar
• Coopman SA, Johnson RA, Platt R, . Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670–1674.
   PubMed Web of Science ®Google Scholar
• Jappe U. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation? Allergy 2007;62:1474–1475.
   PubMed Web of Science ®Google Scholar
• Wharton JM, Coleman DL, Wofsy CB, . Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med 1986;105:37–44.
   PubMed Web of Science ®Google Scholar
• Patel BM. Skin rash with infectious mononucleosis and ampicillin. Pediatrics 1967;40:910–911.
   PubMed Web of Science ®Google Scholar
• Saven A, Burian C, Adusumalli J, . Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia. Blood 1999;93:2471–2477.
   PubMed Web of Science ®Google Scholar
• Juliusson G, Lenkei R, Tjonnfjord G, . Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factor. Ann Oncol 1995;6:371–375.
   PubMed Web of Science ®Google Scholar
• Yoshizawa S, Yasuoka A, Kikuchi Y, . A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000;85:241–244.
   PubMed Web of Science ®Google Scholar
• Cernadas JR, Brockow K, Romano A, . General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010;65:1357–1366.
   PubMed Web of Science ®Google Scholar
• Robak T, Blasinska-Morawiec M, Krykowski E. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Acta Haematol Pol 1992;23:285–290.
   PubMedGoogle Scholar
• Robak T, Sysa-Jedrzejowska A, Robak E, . 2-Chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia. J Med 1997;28:199–209.
   PubMedGoogle Scholar
• Robak T, Blasinska-Morawiec M, Krykowski E, . 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases. Eur J Haematol 1997;59:216–220.
   PubMed Web of Science ®Google Scholar
• Rutella S, Sica S, Rumi C, . Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. Br J Haematol 1996;92:426–428.
   PubMed Web of Science ®Google Scholar
• Larfars G, Uden-Blohme AM, Samuelsson J. Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies. Br J Haematol 1996;94:709–712.
   PubMed Web of Science ®Google Scholar